EMEA-001823-PIP01-15-M02
Key facts
| Invented name |
Artobend
|
| Active substance |
In vitro expanded autologous human articular chondrocytes
|
| Therapeutic area |
Other
|
| Decision number |
P/0043/2021
|
| PIP number |
EMEA-001823-PIP01-15-M02
|
| Pharmaceutical form(s) |
Implantation matrix
|
| Condition(s) / indication(s) |
Treatment of cartilage disorders
|
| Route(s) of administration |
Intra-articular use
|
| Contact for public enquiries |
TETEC Tissue Engineering Technologies AG
Email: info@tetec-ag.de |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|